Kuhn-Régnier F, Natour E, Dhein S, Dapunt O, Geissler H J, LaRosé K, Görg C, Mehlhorn U
Department of Cardiothoracic Surgery, University of Cologne, Germany.
Eur J Cardiothorac Surg. 1999 Jan;15(1):67-74. doi: 10.1016/s1010-7940(98)00289-9.
Continuous perfusion of the coronary arteries with beta-blocker (esmolol)-enriched normothermic blood during cardiac surgery has been suggested as an alternative technique for myocardial protection. The aim of the present study was to compare the beta-blocker technique to Buckberg's blood cardioplegia during coronary artery bypass grafting (CABG).
Sixty patients with coronary artery disease were randomly assigned to either the esmolol group (ES, n = 30) or the blood cardioplegia group (BC, n = 30). During aortic crossclamp ES patients received continuous normothermic coronary perfusion with esmolol-enriched blood. Hearts of the BC group were protected by antegrade cold blood cardioplegia according to Buckberg. We measured left ventricular (LV) contractility using TEE (fractional area of contraction, FAC) and hemodynamic parameters prior to cannulation for cardiopulmonary bypass (CPB), after decannulation, and 4 h postoperatively. Myocardial lactate release was measured prior to aortic cross-clamp, during cross-clamp, and after decannulation. LV biopsies for determination of heat-shock protein (HSP-70), actin pattern and intercellular adhesion-molecule (ICAM-I) as indicators for structural changes were collected prior CPB, at the end of the aortic cross-clamp period, and prior to weaning off CPB.
There was no significant difference between both groups with respect to grafts and cross-clamp time. ES hearts did not release lactate during cross-clamp. In contrast, BC hearts released significant amounts of lactate. Post CPB FAC and hemodynamics under similar inotropic stimulation showed no difference between groups, whereas at 4 h post CPB measurements showed slightly better values in the ES group: cardiac index: ES: 2.9+/-0.1 (SEM) versus BC: 2.6+/-0.1 L/min per m2 (P < 0.05); FAC: ES: 55+/-3 versus BC: 48+/-3% (P < 0.05). HSP-70 and actin pattern showed no difference between groups; however, ICAM-I showed a significantly higher degree of structural changes in BC hearts: 18+/-2 versus ES: 11+/-1% (P < 0.05).
Our data demonstrate that application of the beta-blocker technique during routine CABG was associated with slightly better functional recovery and less structural myocardial alteration as compared with intermittent cold blood cardioplegia, however, both techniques provided equivalent myocardial protection in terms of patient outcome. Future studies are required to investigate if myocardial ischemia minimization by use of the beta-blocker technique may be beneficial in compromized hearts.
有人提出在心脏手术期间用富含β受体阻滞剂(艾司洛尔)的常温血液持续灌注冠状动脉,作为心肌保护的一种替代技术。本研究的目的是在冠状动脉旁路移植术(CABG)期间,将β受体阻滞剂技术与巴克伯格的血液停搏液进行比较。
60例冠心病患者被随机分为艾司洛尔组(ES,n = 30)或血液停搏液组(BC,n = 30)。在主动脉阻断期间,ES组患者接受富含艾司洛尔的血液进行持续常温冠状动脉灌注。BC组患者的心脏根据巴克伯格法采用顺行冷血停搏液进行保护。我们在体外循环(CPB)插管前、拔管后和术后4小时,使用经食管超声心动图(TEE)(收缩面积分数,FAC)测量左心室(LV)收缩力,并测量血流动力学参数。在主动脉阻断前、阻断期间和拔管后测量心肌乳酸释放。在CPB前、主动脉阻断期末和CPB撤离前采集LV活检组织,以测定热休克蛋白(HSP - 70)、肌动蛋白模式和细胞间粘附分子(ICAM - I),作为结构变化的指标。
两组在移植血管和阻断时间方面无显著差异。ES组心脏在阻断期间未释放乳酸。相比之下,BC组心脏释放了大量乳酸。CPB后,在相似的正性肌力刺激下,FAC和血流动力学在两组之间无差异,而在CPB后4小时测量显示ES组的值略好:心脏指数:ES组:2.9±0.1(SEM),BC组:2.6±0.1 L/min per m2(P < 0.05);FAC:ES组:55±3,BC组:48±3%(P < 0.05)。HSP - 70和肌动蛋白模式在两组之间无差异;然而,ICAM - I显示BC组心脏的结构变化程度明显更高:18±2,ES组:11±1%(P < 0.05)。
我们的数据表明,在常规CABG期间应用β受体阻滞剂技术与间歇性冷血停搏液相比,功能恢复略好,心肌结构改变较少,然而,就患者预后而言,两种技术提供了同等的心肌保护。需要进一步的研究来调查使用β受体阻滞剂技术使心肌缺血最小化是否对受损心脏有益。